Heart failure & cardiomyopathies

A nationwide study of the economic burden of obstructive hypertrophic cardiomyopathy in France

Eur Heart J Qual Care Clin OutcomesPublished observational, retrospective study

Authors' conclusion

Obstructive HCM has a high economic burden driven by cardiovascular hospitalizations. Higher disease severity yielded higher costs associated with medical care and sick leave than lower classes. Results support need for new therapies to improve both symptoms and disease severity.

Study context

Population
Adults (≥18) with obstructive hypertrophic cardiomyopathy (HCM) and at least one disease related hospitalization during 2012–18, in France; patients with <1-year follow-up or phenocopy disorders excludedpatients identified, 30,228 patient-year (PYs)
Participants
6,823 adults
Exposure
Costs by disease severity class (New York Heart Association (NYHA) class); annual cost before and after septal reduction therapies (SRT)
Outcome
Total burden
Follow-up
Mean (standard deviation) 4.4 (2.5) years
Methodological detailsdata from the French National Health Data System
  • Data from the French National Health Data System

Main finding

As reported in the abstract

Total burden

€388 million

Cost per PY

€12 824

Observational data: associations, not effects.

Further findings

OutcomeValues
Cost per patient year by NYHA classI €8881 · IV €22 818
Mean sick-leave-related costs per PYI mean €310 · II mean €673 · III mean €757 · IV mean €774
  • Cost per patient year by NYHA class: higher NYHA class was associated with higher cost per patient year

Hospitalizations share of costs

Hospitalizations accounted for most costs
54%
Cardiovascular-related hospitalizations
71%
Disease-related
46%

Mean cost per PY 1 year before vs. after SRT, including the intervention

Before SRT
€13 726
After SRT
€18 565

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

A nationwide study of the economic burden of obstructive hypertrophic cardiomyopathy in France. Eur Heart J Qual Care Clin Outcomes. Published 4 September 2025. doi:10.1093/ehjqcco/qcaf096

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.